ABBOTT LABORATORIES Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Abbott Laboratories quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
  • Abbott Laboratories Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $305M, a 16.9% increase year-over-year.
  • Abbott Laboratories Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $952M, a 14.6% decline year-over-year.
  • Abbott Laboratories annual Income Tax Expense (Benefit) for 2023 was $941M, a 31.5% decline from 2022.
  • Abbott Laboratories annual Income Tax Expense (Benefit) for 2022 was $1.37B, a 20.4% increase from 2021.
  • Abbott Laboratories annual Income Tax Expense (Benefit) for 2021 was $1.14B, a 129% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $952M $305M +$44M +16.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $908M $211M -$33M -13.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $941M $201M -$86M -30% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $1.03B $235M -$88M -27.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $1.12B $261M -$73M -21.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $1.19B $244M -$185M -43.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.37B $287M -$51M -15.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $1.42B $323M -$70M -17.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.49B $334M +$175M +110% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.32B $429M +$179M +71.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.14B $338M +$108M +47% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $1.03B $393M +$204M +108% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $828M $159M +$170M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $658M $250M +$161M +181% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $497M $230M +$39M +20.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $458M $189M +$46M +32.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $412M -$11M -$107M -111% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $519M $89M +$129M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $390M $191M -$101M -34.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $491M $143M -$23M -13.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $514M $96M +$37M +62.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $477M -$40M -$62M -282% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $539M $292M -$1.15B -79.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $1.69B $166M +$101M +155% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $1.58B $59M +$34M +136% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $1.55B $22M -$328M -93.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $1.88B $1.44B +$1.33B +1207% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $550M $65M -$113M -63.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $663M $25M -$91M -78.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $754M $350M +$404M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $350M $110M -$25M -18.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $375M $178M +$60M +50.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $315M $116M -$84M -42% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $399M -$54M -$178M -144% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $577M $135M -$35M -20.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $612M $118M -$159M -57.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $771M $200M -$33M -14.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $804M $124M +$7M +5.98% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $797M $170M +$89M +110% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $708M $277M +$440M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $268M $233M +$108M +86.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $160M $117M +$107M +1070% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $53M $81M +$661M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 -$608M -$163M -$55.4M -51.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$553M $125M +$6.34M +5.34% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$559M $10M -$102M -91.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$457M -$580M -$555M -2206% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $98.1M -$108M -$306M -154% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $404M $119M +$387M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $17.2M $112M -$92.8M -45.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $110M -$25.2M -$352M -108% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-21
Q3 2011 $462M $198M +$25M +14.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $437M -$268M -$535M -200% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $972M $205M -$114M -35.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $1.09B $327M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $173M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $267M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $319M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.